Form 4: Johnson & Johnson Executive Timothy Schmid Reports Stock Transactions
SEC Form 4 Filing
EVP Timothy Schmid reports acquisition and disposal of Johnson & Johnson common stock and restricted share units (RSUs) related to long-term incentive plans.
Summary
- Timothy Schmid, EVP, WW Chair, MedTech at Johnson & Johnson, filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve common stock and restricted share units (RSUs).
- On February 13, 2025, 499 RSUs were converted into common stock.
- On February 14, 2025, 193 shares were withheld for tax payments related to vesting RSUs at a price of $155.26.
- Also on February 14, 2025, 1,765 RSUs were converted into common stock.
- An additional 639 shares were withheld for tax payments on February 14, 2025, at a price of $156.71.
- On February 15, 2025, 1,029 RSUs were converted into common stock.
- On February 18, 2025, 403 shares were sold at a price of $156.15.
- Following these transactions, Schmid directly owns 15,098 shares of common stock and 2,056 RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Executive stock transactions are a routine part of corporate governance and compensation practices. Form 4 filings provide transparency into these transactions, allowing investors to track insider activity.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock units.
- The vesting schedules and terms of the RSUs are typical for long-term incentive plans designed to align executive interests with shareholder value.
- Comparable companies in the pharmaceutical and medical device industries, such as Pfizer (PFE) and Medtronic (MDT), also utilize similar equity-based compensation strategies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation activities.
- Employees may be indirectly affected through the company's overall financial performance and stock valuation.
Key Dates
| Date | Description |
|---|---|
| 02/13/2023 | Date of RSU award that vests in three annual installments. |
| 02/14/2022 | Date of RSU award that vests three years after the grant date. |
| 02/15/2024 | Date of RSU award that vests in three annual installments. |
| 02/13/2025 | Conversion of 499 Restricted Share Units to Common Stock. |
| 02/14/2025 | Withholding of 193 shares for tax payments and conversion of 1,765 Restricted Share Units to Common Stock. |
| 02/15/2025 | Conversion of 1,029 Restricted Share Units to Common Stock. |
| 02/18/2025 | Sale of 403 shares of Common Stock at $156.15. |
Keywords
Form 4, Johnson & Johnson, JNJ, Timothy Schmid, Executive Compensation, Restricted Share Units, Stock Transactions, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.